About
Anteris Technologies is an Australian biotechnology and medical device company based in Brisbane, Queensland. The company specializes in innovative solutions for structural heart disease, particularly focusing on heart valve conditions. Anteris is dedicated to designing and commercializing advanced medical devices that aim to restore healthy heart function by mimicking the natural physiology of the heart. The flagship product of Anteris is the DurAVR® Transcatheter Heart Valve (THV), which is designed to treat aortic stenosis. This valve features a unique single-piece design that closely resembles a healthy aortic valve, promoting natural blood flow. A significant innovation in the DurAVR THV is the ADAPT® anti-calcification tissue technology, which has been clinically proven to remain calcium-free for up to 10 years. Anteris Technologies actively engages in clinical trials and collaborates with partners to develop minimally invasive treatments for various valve diseases, serving a global market that includes regions such as Australia, Europe, North America, and Asia.
Technologies
Keywords
Company Information
-
Employees 140
-
Founded 2006
-
Annual Revenue $2492000
-
Total Funding $178075230
Location
860 Blue Gentian Rd, Eagan, Minnesota, United States, 55121